{"disease":{"id":"stage-i-ii-primary-lung-cancer","name":"stage i ii primary lung cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04314401","title":"National Cancer Institute \"Cancer Moonshot Biobank\"","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02419495","title":"Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":221,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05281237","title":"Avecure Flexible Microwave Ablation Probe For Lung Nodules","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}